How to cope with Brazil's ANVISA Regulatory Challenges
                     How to cope with 
ANVISA's Regulatory 
Challenges
vistaar.ai
Brazil Regulatory Authority
ANVISA – Regulatory Challenges
The Brazilian Health Surveillance Agency, commonly 
known as ANVISA, abbreviated from Portuguese “Agencia 
Nacional de Vigilancia Sanitaria,” is the food and drug 
regulatory agency in Brazil. In the federal public regulatory 
structure, the agency is connected to the Ministry of 
Health. ANVISA has a particular process in which they 
undertake regulatory submissions. Over the years there 
have been several changes to these guidelines and the 
greatest challenge faced by bio and pharmaceutical 
companies in this regards is their lack of proper 
knowledge. 
vistaar.ai
Brazil Regulatory Authority
ANVISA – Regulatory Challenges
Second visible challenge with ANVISA is that the 
regulations are present only in two languages, one is 
Portuguese and the other is English. The English version 
is not for all the content and hence it might be difficult 
for those without knowledge of Portuguese to 
comprehend. 
ANVISA’s registration process is often compared to that 
of the registration process of the US FDA because of 
certain uncanny resemblance. 
vistaar.ai
Brazil Regulatory Authority 
ANVISA – Regulatory Challenges
In case of drugs the updated norms indicate that every drug 
and Active Pharmaceutical Ingredients (APIs) whether 
manufactured in Brazil or has been imported needs to be 
registered under ANVISA. This is an established regulatory 
system that has been running over the years but still there is 
extreme complexity surrounding the registration process 
under the same. 
ANVISA is a new ICH member and thus is going through a 
revision process of all guidelines. Most updated guidelines 
under this regulatory authority is presented in a detailed 
manner and with a proper structure which prevents 
vmistanaru.afiacturers from taking the risk.   
Challenges Faced by ANVISA
Challenges Highlighted by ANVISA
Solution for Regulatory Challges 
Read now at 
Brazil Regulatory Authority
ANVISA – Regulatory Challenges 
vistaar.ai
Thank You
vistaar.ai